 3TC was also found to be active against HBV in collaboration with Drs.Dennis Liotta, Philip Furman and Yung-Chi Cheng.Schinazi’s work led to the discovery of a second nucleoside analog, emtricitabine (FTC), subsequently resulting in a potent, safe nucleoside analog commonly used in treatment regimens.